Journal of Cancer Science and Clinical Therapeutics is an open access, peer reviewed journal publishes articles related to the ever expanding research on Cancer. The journal emphasis on different types cancer, novel discoveries in basic science and treatment of cancer, experimental therapeutics, particularly targeted therapies for personalized cancer medicine.
Journal of Cancer Science and Clinical Therapeutics publishes high-impact, peer-reviewed articles significant advances in translational and clinical cancer research. The Journal publishes original articles, review articles, editorials, letters to the editor, short communication, case reports describing original research in the fields of basic, new techniques in cancer research and therapy, translational and clinical cancer.
All published work with Journal of Cancer Science and Clinical Therapeutics is permanently available in online without any restriction to the reader. Articles published in Journal of Cancer Science and Clinical Therapeutics will be Open Access articles distributed under the terms and conditions of the Creative Commons Attribution License 4.0.
Journal of Cancer Science and Clinical Therapeutics welcomes researchers to submit articles on all cancer types, cancer prevention, diagnosis and treatment. Subject categories include
Fortune Journals offers free advertisement to the conferences, scientific events, technical seminars or symposiums, etc. To advertise in our journal, please contact us at email@example.com
Problem of Breast Cancer Management in the Obstetric-Gynecologic Department of the National Hospital Donka, Teaching Hospital-Conakry
Objective: Describe the diagnosis, therapeutic and prognostic aspects of breast cancer and analyze the survival rate of patients. Materials and methods: We conducted a quasi-retrospective descriptive and analytic study of 4 years from 1st January 2010 to 31st December...Read More
Evaluation of Upper Extremity Deep Vein Thrombosis Risk Factors and Management
Background: Upper extremity deep venous thrombosis (UEDVT) incidence and complications are increasing. We evaluated the risk factors and management for patients diagnosed with an UEDVT. Methods: All patients with an UEDVT in 2014 were evaluated for demographics, throm...Read More
Outcome of Management of Pseudomyxoma Peritonei: National Cancer Institute.
Background: The current treatment for pseudomyxoma peritonei (PMP) consists of radical cytoreductive surgery (CRS) followed by hyperthermic intra-peritoneal chemotherapy (HIPEC).
Aim: To assess PMP patients regarding the clinical a...Read More